DICUT, Inc. Readying Two New Exciting and Innovative Security Products for Upcoming Worldwide Release.Business Editors/High-Tech Writers MARIETTA, Ga.--(BUSINESS WIRE)--Sept. 9, 2003 DICUT, Inc., an advanced security solutions provider, is continuing development on two new innovative security products and eyeing release dates of late September 2003 and early 2004, respectively. The iPassThru(TM) Security System from DICUT's Aurora Biosecurity Solutions division is an all-in-one, plug-n-play access control security system that can limit, control, and monitor entry/exit access to buildings, facilities, and restricted personnel areas. iPassThru(TM) significantly enhances on-site security without passwords or PINs and eliminates unauthorized access and fraudulent use of proximity/swipe cards (including any type of card or badge issued for identification access and travel, i.e. passports, visas, and border crossing cards). Additionally, iPassThru(TM) offers time and attendance record keeping and ensures accurate automated audit tracking by storing an individual's bioprint each time he/she accesses the system. iPassThru(TM) is a cost effective security solution and can be added to existing security controls. DICUT is targeting a release date for the iPassThru(TM) Security System of late September 2003. Aurora Biosecurity Solutions was acquired by DICUT in July 2003 and is headed by Aurora founder, Dr. Helena Wisniewski. DICUT's Detect-X division is continuing development on a line of Universal Detection Devices that employ a proprietary suite of sensors for use in the security, agricultural, and medical fields. The first Detect-X Universal Detection Device is targeted for release in early 2004 and is able to detect the presence of anthrax anthrax (ăn`thrăks), acute infectious disease of animals that can be secondarily transmitted to humans. It is caused by a bacterium (Bacillus anthracis , a bio-terrorism agent. Future developments will include the detection of biological toxins like ricin ricin /ri·cin/ (ri´sin) a phytotoxin in the seeds of the castor oil plant (Ricinus communis), used in the synthesis of immunotoxins. ri·cin n. , explosives and contraband contraband, in international law, goods necessary or useful in the prosecution of war that a belligerent may lawfully seize from a neutral who is attempting to deliver them to the enemy. narcotics narcotics n. 1) techinically, drugs which dull the senses. 2) a popular generic term for drugs which cannot be legally possessed, sold, or transported except for medicinal uses for which a physician or dentist's prescription is required. , bacterial spores bacterial spore, n a bacteria that, because of its thick outer wall, is easily able to survive in hostile environments otherwise not conducive to bacterial growth and reproduction. in food, glucose enzymes, and proteins. Dr. Michael L. Myrick, PI developed the patented technology at the University of South Carolina
• • and in March 2003, DICUT entered into a licensing agreement giving the Detect-X division the exclusive worldwide rights to manufacture, market, and sell the innovative detection technology. Detect-X president, Gus Saponari and chief scientist, Dr. Frederick Haibach, PH.D are leading the development and production of the Detect-X Universal Detection Devices to unobtrusively scan objects in order to detect trace amounts of adulterant a·dul·ter·ant n. An additive causing an undesirable effect; impurity. a·dul  ter·ant adj. materials. The detection devices will provide an enhanced level of security that seamlessly fit into everyday activities in mailrooms, sport and concert venues, convention halls, shopping malls, warehouses, office buildings, public schools, courtrooms, plant and factories, restaurants, hospitals, medical laboratories, etc. "With increased terror threats around the world, there is a heightened awareness regarding security and a need for new and innovative security solutions," said Raj Kalra, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of DICUT, Inc. "Our Aurora Biosecurity Solutions and Detect-X divisions are working to provide cost effective, easy to use products that will significantly enhance security for organizations and individuals. I am excited about the future as we develop these products and work towards the planned release dates. DICUT remains committed to providing advanced security solutions and our iPassThru(TM) Security System and Detect-X Universal Detection Devices are significant steps towards that mission." About DICUT Founded in 1994, DICUT, Inc., (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). .BB: DCUT) is an advanced security solutions provider. DICUT provides security solutions thorough innovative technologies to both the public and private sectors. The company consists of three wholly owned subsidiaries Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Aurora Biosecurity Solutions, Detect-X, and veriCentrix. Aurora Biosecurity Solutions provides fully automated, complete biometric products and systems that grant or deny access with no human intervention. Detect-X is dedicated to developing a new level of innovative security for today's world and the veriCentrix division provides comprehensive solutions for an organization seeking to automate and simplify security. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion